The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: May 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

6. Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion

  • 1. Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma
  • 2. Spatial epitope barcoding reveals clonal tumor patch behaviors
  • 3. Non-viral precision T cell receptor replacement for personalized cell therapy
  • 4. The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
  • 5. Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
  • 6. Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion
  • 7. The NALCN channel regulates metastasis and nonmalignant cell dissemination
  • 8. Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
  • 9. Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer
  • 10. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
Previous
Next

Ablain, J. et al. Nat Genet. 54: 1839–1852 . (2022).
doi: 10.1038/s41588-022-01191-z.

Summary of the findings

Our understanding of the mechanisms driving tumor dissemination is still incomplete, especially in non-epithelial tumors like melanoma. Only few genetic alterations have been shown to promote metastasis and non-genetic events have emerged as major contributors to cancer cell spreading. Here, we describe a cooperation between external stress and genetic abnormalities in the regulation of melanoma metastasis. We identified deletions of the adhesion gene NECTIN1 in approximately half of human melanomas and found that NECTIN1 levels were lower in metastases than in primary tumors. Through experiments in cell lines, zebrafish models and human melanoma samples, we discovered that NECTIN1 loss promotes melanoma dissemination specifically in response to a local drop in insulin-like growth factor 1 (IGF1) concentration. NECTIN1 is required for the formation of adherens junctions, cell-cell contacts typical of epithelial tissues. Surprisingly, IGF1 depletion elicited the robust formation of adherens junctions between NECTIN1-wildtype melanoma cells, suggesting that non-epithelial tumors can form epithelial structures under stress. In contrast, NECTIN1-deficient cells failed to establish these junctions and, instead, activated a cell-matrix adhesion program triggering their migration. These findings uncover a mechanism by which genetic alterations in cell-cell adhesion modulate the response of cancer cells to microenvironmental stress, thus controlling their metastatic behavior.

Future impact

Model for the role of NECTIN1 loss in melanoma dissemination. Image created with Biorender.

Recent evidence suggests a substantial overlap between the migratory state of cancer cells and the resistance to current anti-proliferative drugs. Our results indicate that the migratory state of cancer cells is regulated by a combination of different signals from their microenvironment, including chemical cues, such as growth factors, and physical conditions, such as the presence of neighboring cells to which they can adhere. A deeper understanding of the multiplicity of these signals and their associated pathways inside cancer cells may reveal new therapeutically actionable vulnerabilities of metastatic tumors.

Read more in Nature Genetics

6. Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion

  • 1. Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma
  • 2. Spatial epitope barcoding reveals clonal tumor patch behaviors
  • 3. Non-viral precision T cell receptor replacement for personalized cell therapy
  • 4. The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
  • 5. Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
  • 6. Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion
  • 7. The NALCN channel regulates metastasis and nonmalignant cell dissemination
  • 8. Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
  • 9. Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer
  • 10. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026

The EACR, AACR, and The Mark Foundation for Cancer Research recently teamed up to offer a number of travel grants to help EACR or AACR members...

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026

https://www.youtube.com/watch?v=KdMqmIIgNYo Click above to watch On 9 April 2026, the EACR hosted a free webinar bringing together leading experts to explore the Cancer Genome Interpreter (CGI)...

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

April 13, 2026

What does it take to bridge the gap between researchers and patients? In this episode, scientists, oncologists, and patient advocates from Canada, the United States, and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities
Community

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026
VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter
Features

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR